151.99
151.99 (0%)
As of Feb 14, 2025
Charles River Laboratories International, Inc. [CRL]
Source:
Company Overview
Charles River Laboratories International, Inc is a leading, non-clinical global drug development partner with a mission to create healthier lives. We have built upon our original core competency of laboratory animal medicine and science (research model technologies) to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, that supports our clients from target identification through non-clinical development.
| Country | United States |
| Headquarters | wilmington, massachusetts |
| Phone Number | 781-222-6000 |
| Industry | services |
| CEO | James C. Foster |
| Website | www.criver.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $4,050 |
| Operating Profit | $227.3 |
| Net Income | $25.3 |
| Net Cash | $-78.9 |
Profit Ratios
| Gross Margin | $1,331.8 |
| Operating Margin | 5.6 |
| Profit as % of Revenues | 5,266% |
| Profit as % of Assets | 0.3% |
| Profit as % of Stockholder Equity | 0.7% |
Management Effectiveness
| Return on Equity | 0.7% |
| Return on Assets | 0.3% |
| Turnover Ratio | 51.5% |
| EBITA | $365.8 |
Balance Sheet and Cash Flow Measures
| Total Assets | $7,528.3 |
| Total Liabilities | $4,020.3 |
| Operating Cash Flow | $734.6 |
| Investing Cash Flow | $-245.1 |
| Financing Cash Flow | $-550.9 |
